Evidence map›Paper›PMID 31791942›Full record

ArticleAntimicrobial agents and chemotherapy2020

Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.

Qiangqiang Sun, Kang Xiong, Yuncong Yuan, Jing Yu, Lianjuan Yang, Chao Shen, Chang Su, Yang Lu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. EditingBiomolecules · 2026
    Review
  2. Article
  3. Article
  4. CRISPR-Based Genetic Manipulation ofFrontiers in genome editing · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Qiangqiang SunHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.
Kang XiongHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.
Yuncong YuanHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.
Jing YuHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China.
Lianjuan YangDepartment of Mycology, Shanghai Dermatology Hospital, Shanghai, China.
Chao ShenCollege of Life Sciences, Wuhan University, Wuhan, China.
Chang SuHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China changsu@whu.edu.cn ylu7@whu.edu.cn.
Yang LuHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, China changsu@whu.edu.cn ylu7@whu.edu.cn.ORCID 0000-0002-3784-7577
Wuhan University · CNShanghai Stomatological Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Echinocandin resistance in

Indexed as

Alkyl and Aryl TransferasesAnimalsAntifungal AgentsCandidaCandida albicansCandida glabrataCandida parapsilosisCandidiasis, InvasiveCaspofunginDrug Resistance, FungalDrug SynergismEchinocandinsFemaleHumansMiceMice, Inbred BALB CAlkyl and Aryl TransferasesAntifungal AgentsCaspofunginEchinocandinsgeranylgeranyltransferase type-IPiperazinesantifungal resistanceantifungal therapyCandidadrug developmentGGTase I

Identifiers

PMID31791942
PMCPMC6985710
OpenAlexW2991316350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.